The clinically relevant antidepressant effect in the subgroup of depressed patients with EPA/DHA supplementation as adjunctive to conventional antidepressants that was revealed in the post hoc analysis might provide a basis for a controlled , prospective trial of omega-3 augmentation of antidepressants in patients after myocardial infarction .